- Contract Sales Decrease: China Overseas Land reported a 2% drop in contract sales for August.
- Monthly Revenue: The company achieved contracted sales of 18.46 billion yuan in August.
- Year-to-Date Performance: Year-to-date, the firm’s contracted sales totaled 180.03 billion yuan.
- Analyst Ratings: Among analysts covering China Overseas Land, there are 32 buy recommendations, 1 hold recommendation, and no sell recommendations.
A look at China Overseas Land & Investment Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
China Overseas Land & Investment Limited, a company that provides real estate services, is seen to have a positive long-term outlook based on its Smartkarma Smart Scores. With a strong value and dividend score of 4 each, it indicates good fundamentals and income potential for investors. Although the growth, resilience, and momentum scores are slightly lower at 3, suggesting room for improvement in these areas, the overall outlook remains positive. The company develops, manages, and invests in commercial properties, catering to customers globally.
Investors looking into China Overseas Land & Investment can be encouraged by the solid foundation depicted by the Smart Scores. While there are areas for potential growth and improvement, the company’s emphasis on value and dividend highlights its stability and income-generating potential. As it continues to expand its real estate services and investments in commercial properties on a global scale, China Overseas Land & Investment is positioned to attract investors seeking long-term opportunities in the real estate sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
